CX3CR1 and schizophrenia: Another evidence for this phenomenon was delivered by Gandal et al. [157] whose multifaceted and complex microarray study revealed a robust reduction in both CX3CL1 and CX3CR1 levels in postmortem cortical samples from patients with schizophrenia.